Novel insight into histological and molecular astrocytoma, IDH ‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
Cancer Medicine · 2023-09 · 12 (18) · 18666-18678
DOI: 10.1002/cam4.6476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 05.09.2023. Verfasst von Wenlin Chen und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy o…. Hauptthemen laut MEDLINE: Brain Neoplasms, Astrocytoma, Central Nervous System Neoplasms, Glioblastoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Background
The latest fifth edition of the World Health Organization (WHO) classification of the central nervous system (CNS) tumors (WHO CNS 5 classification) released in 2021 defined astrocytoma, IDH‐ mutant, Grade 4. However, the understanding of this subtype is still limited. We conducted this study to describe the features of astrocytoma, IDH ‐mutant, Grade 4 and explored the similarities and differences between histological and molecular subtypes.
Methods
Patients who underwent surgery from January 2011 to January 2022, classified as astrocytoma, IDH ‐mutant, Grade 4 were included in this study. Clinical, radiological, histopathological, molecular pathological, and survival data were collected for analysis.
Results
Altogether 33 patients with astrocytoma, IDH ‐mutant, Grade 4 were selected, including 20 with histological and 13 with molecular WHO Grade 4 astrocytoma. Tumor enhancement, intratumoral‐necrosis like presentation, larger peritumoral edema, and more explicit tumor margins were frequently observed in histological WHO Grade 4 astrocytoma. Additionally, molecular WHO Grade 4 astrocytoma showed a tendency for relatively longer overall survival, while a statistical significance was not reached (47 vs. 25 months, p = 0.22). TP53 , CDK6 , and PIK3CA alteration was commonly observed, while PIK3R1 ( p = 0.033 ), Notch1 ( p = 0.027 ), and Mycn (p = 0.027) alterations may affect the overall survival of molecular WHO Grade 4 astrocytomas.
Conclusions
Our study scrutinized IDH ‐mutant, Grade 4 astrocytoma. Therefore, further classification should be considered as the prognosis varied between histological and molecular WHO Grade 4 astrocytomas. Notably, therapies aiming at PIK3R1 , Notch 1 , and Mycn may be beneficial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- China Anti-Cancer Association Specialty Committee of Glioma, Beijing, China.
- 4+4 Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Siying Guo, Yaning Wang, Yu Wang
Förderung
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Chen, W., Guo, S., Wang, Y., Shi, Y., Guo, X., Liu, D., Li, Y., Wang, Y., Xing, H., Xia, Y., Li, J., Wu, J., Liang, T., Wang, H., Liu, Q., Jin, S., Qu, T., Li, H., Yang, T., …, & Ma, W. (2023). Novel insight into histological and molecular astrocytoma, IDH ‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors. Cancer Medicine, 12(18), 18666-18678. https://doi.org/10.1002/cam4.6476
Vancouver
Chen W, Guo S, Wang Y, Shi Y, Guo X, Liu D, et al. Novel insight into histological and molecular astrocytoma, IDH ‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors. Cancer Medicine. 2023;12(18):18666-18678. doi:10.1002/cam4.6476
BibTeX
@article{Chen2023,
author = {Chen, Wenlin and Guo, Siying and Wang, Yaning and Shi, Yixin and Guo, Xiaopeng and Liu, Delin and Li, Yilin and Wang, Yuekun and Xing, Hao and Xia, Yu and Li, Junlin and Wu, Jiaming and Liang, Tingyu and Wang, Hai and Liu, Qianshu and Jin, Shanmu and Qu, Tian and Li, Huanzhang and Yang, Tianrui and Zhang, Kun and Wang, Yu and Ma, Wenbin},
title = {Novel insight into histological and molecular astrocytoma, IDH ‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {18},
pages = {18666--18678},
doi = {10.1002/cam4.6476}
}
EUVIMED